# Immucell Corp: Form 8-K, filed Feb 2, 2026

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2026-02-02
- Accepted by EDGAR: Feb 2, 2026, 22:22 ET
- Period: 2026-01-27
- Accession: 0001437749-26-002685
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000143774926002685/iccc20260202_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000143774926002685/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000143774926002685/iccc20260202_8k.htm

Filed Feb 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-002685. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.